Please login to the form below

Not currently logged in
Email:
Password:

Deal Watch December 2015

Medius Deal Watch

The month’s deals see a number of collaboration and licensing deals for technology platforms and new molecule discovery

Adapting to the digital consumer

The trends affecting all segments of the wider healthcare ecosystem

Another lost decade for research?

What does the patent landscape look like for antibiotics, vaccines and orphan drugs?

Deal Watch November 2015

Medius Deal Watch

Deal Watch October 2015

Medius Deal WatchA bumper crop of deals with seven transactions of $1bn or more

Webinars

Meaningful digital initiatives need face time

Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.

Authentic Engagement in Healthcare

Authentic Engagement in Healthcare thumbWhat does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?

Can medical technology afford market access?

Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

Drivers for change – payer value perceptions

In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Video

The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

"Not Another Boring Survey?"

Winning over HCPs… How to Increase Participant Engagement in Healthcare Market Research

What pharma needs to know about genomic data in 2016

Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016.

Seven ambitious data objectives for your marketing content

Data is a great way to connect and align global and local objectives – providing the kind of value that gets local markets engaged in core sales materials and speeding

Part Two: The First Amendment: Physician education using off-label indications to ensure that patients receive the most effective treatment.

In today’s medical environment there is a two-fold element of risk that affects a medical device company. It is comprised on the one hand by the risk of improper treatment

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Infographics